Cytogenetics of extramedullary manifestations in multiple myeloma
Open Access
- 1 February 2013
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 161 (1), 87-94
- https://doi.org/10.1111/bjh.12223
Abstract
Extramedullary disease in patients with multiple myeloma is a rare event, occurring mostly in advanced disease or relapse. Outcome is poor and prognostic factors predicting the development of extramedullary disease have not been defined. We investigated cytogenetic alterations of myeloma cells in different extramedullary manifestations by adapting the fluorescence in situ hybridization (FISH) technique in combination with cytoplasmic immunoglobulin staining to study the cytogenetics of plasma cell tumours on paraffin embedded material. Thirty six patients were investigated: 19 with extramedullary disease, 11 with skeletal extramedullary disease and six with solitary extramedullary plasmacytoma. The first two groups showed the following results: del(17p13) 32% vs. 27%, del(13q14) 35% vs. 27%, MYC‐overrepresentation 28% vs. 18% and t(4;14) 37% vs. 18%. We detected an overall higher incidence of del(17p13) in both groups compared to data from bone marrow samples of multiple myeloma reported to date (range 7–16%). The solitary extramedullary plasmacytomas presented overall less cytogenetic aberrations than the other groups. Most important, three patients with extramedullary disease and one with skeletal extramedullary disease presented different FISH findings in the extramedullary tumour compared to their bone marrow plasma cells. del(17p13), occurring additional in three of four cases, seems a strong marker for extramedullary progression of myeloma.Keywords
This publication has 33 references indexed in Scilit:
- Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment ApproachJournal of Clinical Oncology, 2011
- Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaLeukemia, 2011
- Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic contextHaematologica, 2009
- Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogeneticsHaematologica, 2008
- Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeBlood, 2007
- Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletionsBritish Journal of Haematology, 2004
- Categorical Data AnalysisWiley Series in Probability and Statistics, 2002
- Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationBlood, 2002
- Incidence and prognostic significance of deletions of tumor suppressor genes and aneuploidies in multiple myeloma: an interphase FISH studyEuropean Journal Of Cancer, 2001
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975